Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner appears with an NIH announcement about updates to terminology used across NIH content.SummaryDifference1%

- Check21 days agoChange DetectedThe site footer now lists revision v3.7.2 instead of v3.7.1. The study page continues to show a 403 error.SummaryDifference0.3%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study page now renders a 403 Forbidden error, blocking access to the record. Core study details and related information are no longer visible on the page.SummaryDifference21%

- Check69 days agoChange DetectedThe page footer's revision label changed from v3.6.5 to v3.6.6, signaling a backend/template update rather than a content change.SummaryDifference0.0%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.